<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1169" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1169/" /><meta name="ncbi_pagename" content="Autosomal Dominant Nocturnal Frontal Lobe Epilepsy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Autosomal Dominant Nocturnal Frontal Lobe Epilepsy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Autosomal Dominant Nocturnal Frontal Lobe Epilepsy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/15" /><meta name="citation_author" content="Hirokazu Kurahashi" /><meta name="citation_author" content="Shinichi Hirose" /><meta name="citation_pmid" content="20301348" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1169/" /><meta name="citation_keywords" content="ADNFLE" /><meta name="citation_keywords" content="ADNFLE" /><meta name="citation_keywords" content="Corticoliberin" /><meta name="citation_keywords" content="GATOR complex protein DEPDC5" /><meta name="citation_keywords" content="Neuronal acetylcholine receptor subunit alpha-2" /><meta name="citation_keywords" content="Neuronal acetylcholine receptor subunit alpha-4" /><meta name="citation_keywords" content="Neuronal acetylcholine receptor subunit beta-2" /><meta name="citation_keywords" content="Potassium channel subfamily T member 1" /><meta name="citation_keywords" content="CHRNA2" /><meta name="citation_keywords" content="CHRNA4" /><meta name="citation_keywords" content="CHRNB2" /><meta name="citation_keywords" content="CRH" /><meta name="citation_keywords" content="DEPDC5" /><meta name="citation_keywords" content="KCNT1" /><meta name="citation_keywords" content="Autosomal Dominant Nocturnal Frontal Lobe Epilepsy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Autosomal Dominant Nocturnal Frontal Lobe Epilepsy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Hirokazu Kurahashi" /><meta name="DC.Contributor" content="Shinichi Hirose" /><meta name="DC.Date" content="2018/03/15" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1169/" /><meta name="description" content="Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is characterized by clusters of nocturnal motor seizures, which are often stereotyped and brief (5 seconds to 5 minutes). They vary from simple arousals from sleep to dramatic, often bizarre hyperkinetic events with tonic or dystonic features. Affected individuals may experience aura. Retained awareness during seizures is common. A minority of individuals experience daytime seizures. Onset ranges from infancy to adulthood. About 80% of individuals develop ADNFLE in the first two decades of life; mean age of onset is ten years. Clinical neurologic examination is normal and intellect is usually preserved, but reduced intellect, psychiatric comorbidity, or cognitive deficits may occur. Within a family, the manifestations of the disorder may vary considerably. ADNFLE is lifelong but not progressive. As an individual reaches middle age, attacks may become milder and less frequent." /><meta name="og:title" content="Autosomal Dominant Nocturnal Frontal Lobe Epilepsy" /><meta name="og:type" content="book" /><meta name="og:description" content="Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is characterized by clusters of nocturnal motor seizures, which are often stereotyped and brief (5 seconds to 5 minutes). They vary from simple arousals from sleep to dramatic, often bizarre hyperkinetic events with tonic or dystonic features. Affected individuals may experience aura. Retained awareness during seizures is common. A minority of individuals experience daytime seizures. Onset ranges from infancy to adulthood. About 80% of individuals develop ADNFLE in the first two decades of life; mean age of onset is ten years. Clinical neurologic examination is normal and intellect is usually preserved, but reduced intellect, psychiatric comorbidity, or cognitive deficits may occur. Within a family, the manifestations of the disorder may vary considerably. ADNFLE is lifelong but not progressive. As an individual reaches middle age, attacks may become milder and less frequent." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1169/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/adnfle/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1169/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D2BCFE040E3F10000000003080119.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1169_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1169_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lad-ad/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rob-ad/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1169_"><span class="title" itemprop="name">Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: ADNFLE</div><p class="contrib-group"><span itemprop="author">Hirokazu Kurahashi</span>, MD, PhD and <span itemprop="author">Shinichi Hirose</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1169_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1169_ai__"><div class="contrib half_rhythm"><span itemprop="author">Hirokazu Kurahashi</span>, MD, PhD<div class="affiliation small">Aichi Medical University<br />Nagakute, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.u-dem-ihcia.liam@637.uzakorih.ihsaharuk" class="oemail">pj.ca.u-dem-ihcia.liam@637.uzakorih.ihsaharuk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Shinichi Hirose</span>, MD, PhD<div class="affiliation small">Fukuoka University<br />Fukuoka, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.u-akoukuf@esorih" class="oemail">pj.ca.u-akoukuf@esorih</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 16, 2002</span>; Last Update: <span itemprop="dateModified">March 15, 2018</span>.</p><p><em>Estimated reading time: 27 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="adnfle.Summary" itemprop="description"><h2 id="_adnfle_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is characterized by clusters of nocturnal motor seizures, which are often stereotyped and brief (5 seconds to 5 minutes). They vary from simple arousals from sleep to dramatic, often bizarre hyperkinetic events with tonic or dystonic features. Affected individuals may experience aura. Retained awareness during seizures is common. A minority of individuals experience daytime seizures. Onset ranges from infancy to adulthood. About 80% of individuals develop ADNFLE in the first two decades of life; mean age of onset is ten years. Clinical neurologic examination is normal and intellect is usually preserved, but reduced intellect, psychiatric comorbidity, or cognitive deficits may occur. Within a family, the manifestations of the disorder may vary considerably. ADNFLE is lifelong but not progressive. As an individual reaches middle age, attacks may become milder and less frequent.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of ADNFLE is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has suggestive clinical findings combined with a family history that is positive for other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and/or by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CHRNA4</i>, <i>CHRNB2</i>, <i>CHRNA2</i>, <i>KCNT1</i>, <i>DEPDC5</i>, or <i>CRH</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Carbamazepine is associated with remission in about 70% of individuals, often in relatively low doses. Individuals with ADNFLE associated with the <i>CHRNA4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1169/table/adnfle.T.chrna4_pathogenic_variants_disc/?report=objectonly" target="object" rid-figpopup="figadnfleTchrna4pathogenicvariantsdisc" rid-ob="figobadnfleTchrna4pathogenicvariantsdisc">p.Ser284Leu</a> are more responsive to zonisamide than carbamazepine. Resistance to AEDs, present in about 30% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, requires a trial of all appropriate AEDs. Adjunctive fenofibrate therapy or vagal nerve stimulation may be considered for individuals resistant to AEDs.</p><p><i>Surveillance</i>: Reevaluation of EEGs at regular intervals to monitor disease progression.</p><p><i>Evaluation of relatives at risk:</i> A medical history from relatives at risk can identify those with ADNFLE so that treatment can be initiated promptly.</p><p><i>Pregnancy management:</i> Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception. Transitioning to a lower-risk medication prior to pregnancy may be possible.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ADNFLE is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with ADNFLE have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. The proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown, as the frequency of subtle signs of the disorder in parents has not been thoroughly evaluated and molecular genetic data are insufficient. Penetrance is estimated at 70% and the risk to each offspring of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 50%; thus, the chance that the offspring will manifest ADNFLE is (50% x 70% =) 35%. Prenatal testing for pregnancies at increased risk is possible.</p></div></div><div id="adnfle.Diagnosis"><h2 id="_adnfle_Diagnosis_">Diagnosis</h2><div id="adnfle.Suggestive_Findings"><h3>Suggestive Findings</h3><p>No formal diagnostic criteria for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy (ADNFLE) have been published. ADNFLE <b>should be suspected</b> in individuals with the following clinical features, EEG findings, neuroimaging, and family history.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Clusters of brief (5-second to 5-minute) nocturnal motor seizures that are often stereotyped and may include:</div><ul><li class="half_rhythm"><div>Nightmares</div></li><li class="half_rhythm"><div>Verbalizations</div></li><li class="half_rhythm"><div>Sudden limb movements</div></li><li class="half_rhythm"><div>Parasomnias (undesirable phenomena that occur mainly or only during sleep)</div></li></ul></li><li class="half_rhythm"><div>Preserved intellect, although reduced intellect, cognitive deficits, or psychiatric comorbidity may occur</div></li><li class="half_rhythm"><div>Normal clinical neurologic examination</div></li></ul><p>Note: The clinical features of ADNFLE are indistinguishable from those of nonfamilial NFLE [<a class="bk_pop" href="#adnfle.REF.hayman.1997.969">Hayman et al 1997</a>, <a class="bk_pop" href="#adnfle.REF.tenchini.1999.637">Tenchini et al 1999</a>, <a class="bk_pop" href="#adnfle.REF.steinlein.2000.529">Steinlein et al 2000</a>].</p><p><b>EEG findings</b></p><ul><li class="half_rhythm"><div>Clusters of seizures with a frontal semiology</div></li><li class="half_rhythm"><div>Ictal EEG that may be normal or obscured by movement artifact</div></li><li class="half_rhythm"><div>Interictal EEG that shows infrequent epileptiform discharges</div></li></ul><p><b>Neuroimaging.</b> Normal findings</p><p><b>Family history</b></p><ul><li class="half_rhythm"><div>Consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance [<a class="bk_pop" href="#adnfle.REF.tassinari.1997">Tassinari &#x00026; Michelucci 1997</a>, <a class="bk_pop" href="#adnfle.REF.provini.1999.1017">Provini et al 1999</a>, <a class="bk_pop" href="#adnfle.REF.combi.2004.923">Combi et al 2004</a>]</div></li><li class="half_rhythm"><div>Note: Absence of a known family history of ADNFLE does not preclude the diagnosis.</div></li></ul></div><div id="adnfle.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of ADNFLE <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the clinical features and findings detailed in <a href="#adnfle.Suggestive_Findings">Suggestive Findings</a> combined with a family history that is positive for other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and/or by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the genes listed in <a class="figpopup" href="/books/NBK1169/table/adnfle.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figadnfleTmoleculargenetictestingused" rid-ob="figobadnfleTmoleculargenetictestingused">Table 1</a>.</p><p>Molecular genetic testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> is based on the order in which pathogenic variants most commonly occur (i.e., <i>CHRNA4</i>, <i>CHRNB2</i>, <i>KCNT1</i>, <i>DEPDC5</i>, <i>CHRNA2</i>, and <i>CRH</i>).</div><div class="half_rhythm">If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> may be considered.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CHRNA4</i>, <i>CHRNB2</i>, <i>CHRNA2</i>, <i>KCNT1</i>, <i>DEPDC5</i>, <i>CRH</i>, and other genes of interest (see <a href="#adnfle.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="adnfle.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1169/table/adnfle.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adnfle.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of ADNFLE Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by This Method</th></tr><tr><th headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNA2</i></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>6</sup></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3 hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>6</sup></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3 hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_2" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNA4</i></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%-15%&#x000a0;<sup>8</sup></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3 hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%-15%&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNB2</i></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lower than in <i>CHRNA4</i>&#x000a0;<sup>8</sup></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3 hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lower than in <i>CHRNA4</i>&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CRH</i></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>9</sup></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3 hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DEPDC5</i></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%&#x000a0;<sup>10</sup></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3 hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNT1</i></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%&#x000a0;<sup>11</sup></td><td headers="hd_h_adnfle.T.molecular_genetic_testing_used_1_1_1_3 hd_h_adnfle.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%&#x000a0;<sup>11</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="adnfle.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="adnfle.TF.1.2"><p class="no_margin">See <a href="/books/NBK1169/#adnfle.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="adnfle.TF.1.3"><p class="no_margin">See <a href="#adnfle.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="adnfle.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="adnfle.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="adnfle.TF.1.6"><p class="no_margin">Reported in two families [<a class="bk_pop" href="#adnfle.REF.aridon.2006.342">Aridon et al 2006</a>, <a class="bk_pop" href="#adnfle.REF.conti.2015.1520">Conti et al 2015</a>]</p></div></dd><dt>7. </dt><dd><div id="adnfle.TF.1.7"><p class="no_margin">To date, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications have not been detected in ADNFLE.</p></div></dd><dt>8. </dt><dd><div id="adnfle.TF.1.8"><p class="no_margin">10%-15% of individuals with a family history have pathogenic variants in subunits of nicotinic acetylcholine receptor [<a class="bk_pop" href="#adnfle.REF.ferinistrambi.2012.343">Ferini-Strambi et al 2012</a>].</p></div></dd><dt>9. </dt><dd><div id="adnfle.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.combi.2005.899">Combi et al [2005]</a>, <a class="bk_pop" href="#adnfle.REF.sansoni.2013.e61306">Sansoni et al [2013]</a></p></div></dd><dt>10. </dt><dd><div id="adnfle.TF.1.10"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.picard.2014.2101">Picard et al [2014]</a></p></div></dd><dt>11. </dt><dd><div id="adnfle.TF.1.11"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.heron.2012.1188">Heron et al [2012]</a></p></div></dd></dl></div></div></div></div></div><div id="adnfle.Clinical_Characteristics"><h2 id="_adnfle_Clinical_Characteristics_">Clinical Characteristics</h2><div id="adnfle.Clinical_Description"><h3>Clinical Description</h3><p>Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is characterized by clusters of nocturnal motor seizures with a range of manifestations.</p><p><b>Nocturnal seizures.</b> The history may be obtained from the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and witnesses, and supplemented if necessary by video-EEG monitoring.</p><p>Seizures may occur in any stage of sleep, although typically in clusters in non-REM (NREM) sleep, most commonly in stage 2 sleep [<a class="bk_pop" href="#adnfle.REF.picard.2012">Picard &#x00026; Scheffer 2012</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual often goes back to sleep rapidly after a seizure, only to be awakened by another event.</p><p>The seizures are often stereotyped and brief (5 seconds to 5 minutes); they vary from simple arousals from sleep to dramatic hyperkinetic events with tonic or dystonic features. The hyperkinetic manifestations may appear bizarre, sometimes with ambulation, bicycling movements, ballism (flinging or throwing arm movements), and pelvic thrusting movements.</p><p>The three distinct sub-classifications of seizure types based on clinical features of the seizures (semiology) and their duration are "paroxysmal arousals," "paroxysmal dystonia," and "episodic wandering."</p><ul><li class="half_rhythm"><div>Paroxysmal arousal is characterized by abrupt recurrent arousals from NREM sleep associated with a stereotypic motor pattern.</div></li><li class="half_rhythm"><div>Paroxysmal dystonia is characterized by recurrent motor attacks with dystonic-dyskinetic features arising from NREM sleep and usually lasting less than two minutes.</div></li><li class="half_rhythm"><div>Episodic wandering is somnambulic agitated behavior arising from NREM sleep.</div></li></ul><p>The reported frequency ranges from one to 20 attacks each night, a mean of 20 seizures per month; about 60% of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported more than 15 seizures per month.</p><p>Retained awareness during seizures is common and may cause <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals to fear falling asleep. A sense of difficulty breathing and hyperventilation may occur, as well as vocalization, clonic features, urinary incontinence, and secondary generalization.</p><p>Some individuals experience an aura preceding the seizure during sleep and are aware of the onset. Aura may be nonspecific or may consist of numbness in one limb, fear, a shiver, vertigo, or a feeling of falling or being pushed.</p><p>Note: A minority of individuals experience daytime seizures, typically during a period of poor seizure control. Some of the seizures reported are paroxysmal dystonia similar to those during sleep, and others are generalized tonic-clonic seizures, generalized atonic seizures, and focal seizures with impairment of consciousness or awareness.</p><p><b>EEG findings</b></p><ul><li class="half_rhythm"><div>Ictal EEG recordings may be normal or may be obscured by movement artifact. Ictal rhythms, if present, are usually sharp waves or repetitive 8- to 11-Hz spikes. Recruiting patterns and rhythmic theta (bifrontal, unilateral frontal, or with diffuse desynchronization) are occasionally seen [<a class="bk_pop" href="#adnfle.REF.picard.2012">Picard &#x00026; Scheffer 2012</a>]. <a class="bk_pop" href="#adnfle.REF.el_helou.2008.2201">El Helou et al [2008]</a> suggest that seizures may be initiated by K-complexes.</div></li><li class="half_rhythm"><div>Interictal waking EEG shows anterior quadrant epileptiform activity in very few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Interictal sleep EEG may show infrequent epileptiform discharges.</div></li></ul><p><b>Cognitive findings.</b> Clinical neurologic examination is normal and intellect is usually preserved [<a class="bk_pop" href="#adnfle.REF.oldani.1996.964">Oldani et al 1996</a>, <a class="bk_pop" href="#adnfle.REF.nakken.1999.88">Nakken et al 1999</a>]; however, in some individuals neuropsychological assessment reveals reduced intellect, cognitive deficits, or psychiatric comorbidity [<a class="bk_pop" href="#adnfle.REF.khatami.1998.809">Khatami et al 1998</a>, <a class="bk_pop" href="#adnfle.REF.provini.1999.1017">Provini et al 1999</a>, <a class="bk_pop" href="#adnfle.REF.picard.2000.1247">Picard et al 2000</a>, <a class="bk_pop" href="#adnfle.REF.cho.2003.1625">Cho et al 2003</a>, <a class="bk_pop" href="#adnfle.REF.wood.2010.531">Wood et al 2010</a>].</p><p><a class="bk_pop" href="#adnfle.REF.picard.2009.354">Picard et al [2009]</a> found below-normal general intellect in five (45%) of 11 subjects with special difficulty in executive tasks and concluded that cognitive dysfunction is an integral part of ADNFLE caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the nicotinic receptor (see <a href="#adnfle.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>).</p><p><a class="bk_pop" href="#adnfle.REF.magnusson.2003.91">Magnusson et al [2003]</a> reported an increase in psychiatric symptoms in families with ADNFLE (see <a href="#adnfle.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>).</p><p><b>Familial variation.</b> Within a family, the manifestations of the disorder may vary considerably; individuals with subtle manifestations may not present for medical attention.</p><p>A high incidence of true parasomnias has been reported in relatives of those with ADNFLE [<a class="bk_pop" href="#adnfle.REF.provini.1999.1017">Provini et al 1999</a>]. True parasomnias were distinguished from epileptic seizures because of their age-dependent course, the rarity of episodes, and their being not violent and often not disturbing for the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual. They often ended well before the onset of the clear-cut epileptic seizures.</p><p><b>Onset and prognosis.</b> ADNFLE is lifelong but not progressive. Onset ranges from infancy to adulthood. About 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop ADNFLE in the first two decades of life; mean age of onset is ten years. As an individual reaches middle age, attacks may become milder and less frequent. Seizures may vary over time; for example, tonic attacks appearing in early childhood may evolve into seizures with dystonic or hyperkinetic components in later childhood.</p></div><div id="adnfle.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p><b><i>KCNT1.</i></b> Individuals with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>KCNT1</i> may have a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than those with neuronal nicotinic acetylcholine receptor (nAChR) pathogenic variants [<a class="bk_pop" href="#adnfle.REF.heron.2012.1188">Heron et al 2012</a>]:</p><ul><li class="half_rhythm"><div>Affected individuals are more likely to display psychiatric and behavioral problems.</div></li><li class="half_rhythm"><div>Affected individuals are more likely to have a lower age of onset, complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, and cognitive comorbidities.</div></li></ul></div><div id="adnfle.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><a class="bk_pop" href="#adnfle.REF.steinlein.2012.118">Steinlein et al [2012]</a> suggested that certain nAchR pathogenic variants may be associated with an increased risk for cognitive dysfunction. Marked intrafamilial variation in severity is seen, the reasons for which are unknown.</p></div><div id="adnfle.Penetrance"><h3>Penetrance</h3><p>Penetrance is estimated at 70%. <i>KCNT1</i>-related ADNFLE demonstrates complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> compared to 60%-80% in nAChR-related ADNFLE.</p></div><div id="adnfle.Prevalence"><h3>Prevalence</h3><p>The number of families with ADNFLE reported exceeds 100 [<a class="bk_pop" href="#adnfle.REF.picard.2007">Picard &#x00026; Brodtkorb 2007</a>], but no accurate data concerning the prevalence of ADNFLE exist. It is likely that the disorder is underdiagnosed, or in some cases misdiagnosed.</p><p>Families with the disorder have been identified worldwide [<a class="bk_pop" href="#adnfle.REF.steinlein.2014.1">Steinlein 2014</a>].</p></div></div><div id="adnfle.Genetically_Related_Allelic_Disor"><h2 id="_adnfle_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>CHRNA4</i>, <i>CHRNB2</i>, or <i>CRH.</i></p><p><b><i>CHRNA2.</i></b> A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CHRNA2</i> was reported in a family with benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile seizures [<a class="bk_pop" href="#adnfle.REF.trivisano.2015.e53">Trivisano et al 2015</a>].</p><p><b><i>DEPDC5.</i></b> Pathogenic variants in <i>DEPDC5</i> are associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> focal epilepsies including familial temporal lobe epilepsy and familial focal epilepsy with variable foci. Pathogenic variants in <i>DEPDC5</i> have also been identified in individuals with rolandic epilepsy, unclassified focal childhood epilepsy, and focal epilepsy with cortical dysplasia. See <a href="/books/n/gene/depdc5-epilepsy/"><i>DEPDC5</i>-Related Epilepsy</a>.</p><p><b><i>KCNT1.</i></b> Pathogenic variants in <i>KCNT1</i> are also associated with epilepsy with migrating focal seizures (EIMFS). See <a href="/books/n/gene/kcnt1-epilepsy/"><i>KCNT1</i>-Related Epilepsy</a>.</p></div><div id="adnfle.Differential_Diagnosis"><h2 id="_adnfle_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy (ADNFLE) includes conditions of varied etiology.</p><p><b>Normal sleep</b> is characterized by periodic arousals, and occasionally other sleep-related movements or phenomena including nightmares [<a class="bk_pop" href="#adnfle.REF.phillips.1998.1108">Phillips et al 1998</a>].</p><p><b>Parasomnias</b> (disorders in which undesirable physical and mental phenomena occur mainly or exclusively during sleep [<a class="bk_pop" href="#adnfle.REF1">American Academy of Sleep Medicine 2001</a>]) including the following may be considered:</p><ul><li class="half_rhythm"><div><b><i>Pavor nocturnus</i> (night terrors),</b> a common childhood syndrome, is characterized by attacks of extreme fear and distress that occur one or two hours after the child falls asleep. The child is unaware during the attack, which lasts five to ten minutes, and is amnesic for the event the following day [<a class="bk_pop" href="#adnfle.REF.schenck.2000.145">Schenck &#x00026; Mahowald 2000</a>].</div></li><li class="half_rhythm"><div><b>Benign somnambulism (sleep walking)</b> is not accompanied by abnormal motor behavior or dystonia and is usually a self-limiting disorder of childhood. Somnambulism is often <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>.</div></li></ul><p><b>Hysteria</b> is often considered because the individual retains awareness during the attacks, which can be bizarre. Clues to the organic nature of attacks are the occurrence during sleep and the stereotyped semiology (sequence of observed events during the attack).</p><p><b>Periodic limb movement disorder (nocturnal myoclonus)</b> affects the flexor muscles of the lower limbs and is characterized by segmental motor activity in muscles that recurs every 20-30 seconds. Brief stationary movements may be followed by myoclonic or repetitive clonic jerks that coincide with the periodic K-complexes of light sleep.</p><p><b>Restless legs syndrome</b> is often accompanied by segmental motor activity and may be a spinal cord-mediated disorder.</p><p><b>REM sleep disorders</b> may include prominent motor and verbal manifestations that are often of unknown cause or secondary to other neurologic disorders. REM sleep disorders typically occur in men ages 55-60 years. Polysomnography is a useful diagnostic tool.</p><p><b>Respiratory disorders</b> such as asthma may be considered because of difficulty breathing.</p><p><b>Obstructive sleep apnea</b> may be considered in individuals complaining of daytime sleepiness who are not aware of their nocturnal attacks.</p></div><div id="adnfle.Management"><h2 id="_adnfle_Management_">Management</h2><div id="adnfle.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy (ADNFLE) the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>In addition to the evaluation for epilepsy, cognitive and behavioral assessment to help determine the extent of disease</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="adnfle.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>In about 70% of individuals with ADNFLE, carbamazepine is associated with remission of seizures, often with relatively low doses. However, individuals with ADNFLE associated with the <i>CHRNA4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1169/table/adnfle.T.chrna4_pathogenic_variants_disc/?report=objectonly" target="object" rid-figpopup="figadnfleTchrna4pathogenicvariantsdisc" rid-ob="figobadnfleTchrna4pathogenicvariantsdisc">p.Ser284Leu</a> respond only partially to carbamazepine and are more responsive to zonisamide [<a class="bk_pop" href="#adnfle.REF.provini.1999.1017">Provini et al 1999</a>, <a class="bk_pop" href="#adnfle.REF.ito.2000.52">Ito et al 2000</a>, <a class="bk_pop" href="#adnfle.REF.combi.2004.923">Combi et al 2004</a>].</p><p>Exposure to quinidine significantly reduces gain of function for <i>KCNT1</i> pathogenic variants implicated in ADNFLE and EIMFS [<a class="bk_pop" href="#adnfle.REF.milligan.2014.581">Milligan et al 2014</a>]. Clinical treatment with quinidine was reported in a child with EIMFS [<a class="bk_pop" href="#adnfle.REF.bearden.2014.457">Bearden et al 2014</a>], and correlated with a marked reduction in seizure frequency. In the future, it may be also possible to treat <i>KCNT1</i>-related ADNFLE with quinidine.</p><p><b>Resistance to AEDs</b> occurs in about 30% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Intrafamilial variation in pharmaco-responsiveness occurs; therefore, all appropriate AEDs should be tried.</p><p>Adjunctive therapy with fenofibrate reduced seizure frequency in individuals with pharmacoresistant ADNFLE/NFLE in one study [<a class="bk_pop" href="#adnfle.REF.puligheddu.2017.1762">Puligheddu et al 2017</a>].</p><p>Vagal nerve stimulation may be considered for individuals with resistance to AEDs [<a class="bk_pop" href="#adnfle.REF.carre_o.2010.155">Carre&#x000f1;o et al 2010</a>].</p><div id="adnfle.Caregivers"><h4>Caregivers</h4><p>For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child <u>Toolkit</u></a>.</p></div></div><div id="adnfle.Prevention_of_Secondary_Complicat"><h3>Prevention of Secondary Complications</h3><p>Prompt diagnosis and appropriate treatment for ADNFLE can help prevent morning tiredness and daytime somnolence resulting from sleep fragmentation due to seizure-related arousals.</p></div><div id="adnfle.Surveillance"><h3>Surveillance</h3><p>Serial evaluation of EEGs to monitor disease progression is appropriate.</p></div><div id="adnfle.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment:</p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk relatives.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known, a medical history to seek evidence of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> status should be elicited from relatives at risk.</div></li></ul><p>See <a href="#adnfle.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="adnfle.Pregnancy_Management"><h3>Pregnancy Management</h3><p>In general, women with epilepsy or a seizure disorder from any cause are at greater risk for mortality during pregnancy than pregnant women without a seizure disorder; use of antiepileptic medication during pregnancy reduces this risk. However, exposure to antiepileptic medication may increase the risk for adverse fetal outcome (depending on the drug used, the dose, and the stage of pregnancy at which medication is taken). Nevertheless, the risk of an adverse outcome to the fetus from antiepileptic medication exposure is often less than that associated with exposure to an untreated maternal seizure disorder. Therefore, use of antiepileptic medication to treat a maternal seizure disorder during pregnancy is typically recommended. Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception. Transitioning to a lower-risk medication prior to pregnancy may be possible [<a href="https://www.ncbi.nlm.nih.gov/books/NBK1293/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sarma et al 2016</a>].</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="adnfle.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="adnfle.Genetic_Counseling"><h2 id="_adnfle_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="adnfle.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="adnfle.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with ADNFLE have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with ADNFLE may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>CHRNA4</i>, <i>CHRNB2</i>, <i>CHRNA2</i>, <i>KCNT1</i>, <i>DEPDC5</i>, or <i>CRH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is unknown, as the frequency of subtle signs of the disorder in parents has not been thoroughly evaluated and molecular genetic data are insufficient. In one report a mother with a <i>de novo</i> pathogenic variant passed the condition on to her son [<a class="bk_pop" href="#adnfle.REF.phillips.2000.264">Phillips et al 2000</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a child with nocturnal frontal lobe epilepsy and no known family history of NFLE include a detailed clinical and family history and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has been identified).</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (though theoretically possible, no instances of germline mosaicism have been reported).</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with ADNFLE may appear to be negative because of failure to recognize the disorder in family members or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of a proband depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If one parent has phenotypic features of ADNFLE and/or is known to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to each sib of inheriting the pathogenic variant is 50%. The chance that the sib will manifest ADNFLE is (50% x 70% =) 35%, assuming <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of 70%.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with ADNFLE has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The chance that the offspring will manifest ADNFLE is (50% x70% =) 35%, assuming <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of 70%.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with ADNFLE or has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="adnfle.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#adnfle.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Other <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> issues.</b> Individuals may not be aware of the significance of their attacks; in some families, individuals may be reluctant to reveal their symptoms [<a class="bk_pop" href="#adnfle.REF.picard.2012">Picard &#x00026; Scheffer 2012</a>].</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b>. When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="adnfle.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>If the ADNFLE&#x02013;related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="adnfle.Resources"><h2 id="_adnfle_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="http://www.ninds.nih.gov/disorders/epilepsy/epilepsy.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy Information Page</a></div></li></ul></div><div id="adnfle.Molecular_Genetics"><h2 id="_adnfle_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="adnfle.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Autosomal Dominant Nocturnal Frontal Lobe Epilepsy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1169/table/adnfle.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adnfle.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_adnfle.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_adnfle.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_adnfle.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_adnfle.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_adnfle.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_adnfle.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_adnfle.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1135" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHRNA2</i></a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1135" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8p21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15822" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neuronal acetylcholine receptor subunit alpha-2</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CHRNA2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA2 database</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHRNA2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA2</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHRNA2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA2</a></td></tr><tr><td headers="hd_b_adnfle.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1137" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHRNA4</i></a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1137" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20q13<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P43681" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neuronal acetylcholine receptor subunit alpha-4</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CHRNA4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA4 database</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHRNA4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA4</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHRNA4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA4</a></td></tr><tr><td headers="hd_b_adnfle.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1141" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHRNB2</i></a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1141" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q21<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P17787" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neuronal acetylcholine receptor subunit beta-2</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CHRNB2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNB2 database</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHRNB2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNB2</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHRNB2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNB2</a></td></tr><tr><td headers="hd_b_adnfle.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1392" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CRH</i></a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1392" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q13<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P06850" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Corticoliberin</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CRH" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CRH database</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CRH" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CRH</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CRH[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CRH</a></td></tr><tr><td headers="hd_b_adnfle.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9681" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DEPDC5</i></a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9681" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q12<wbr style="display:inline-block"></wbr>​.2-q12.3</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75140" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GATOR complex protein DEPDC5</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DEPDC5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DEPDC5</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DEPDC5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DEPDC5</a></td></tr><tr><td headers="hd_b_adnfle.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57582" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNT1</i></a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57582" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q34<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q5JUK3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium channel subfamily T member 1</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNT1</a></td><td headers="hd_b_adnfle.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNT1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNT1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="adnfle.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="adnfle.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (<a href="/omim/118502,118504,118507,122560,600513,603204,605375,608167,614191" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1169/table/adnfle.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adnfle.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/118502" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">118502</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2; CHRNA2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/118504" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">118504</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/118507" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">118507</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/122560" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">122560</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CORTICOTROPIN-RELEASING HORMONE; CRH</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600513" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600513</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603204" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603204</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605375" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605375</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608167" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608167</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 1; KCNT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614191" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614191</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DEP DOMAIN-CONTAINING PROTEIN 5; DEPDC5</td></tr></tbody></table></div></div><div id="adnfle.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>The genes in which pathogenic variants are known to cause ADNFLE:</p><ul><li class="half_rhythm"><div class="half_rhythm">Genes encoding subunits of the neuronal nicotinic acetylcholine receptor (nAChR):</div><ul><li class="half_rhythm"><div><b><i>CHRNA4</i>,</b> encoding the &#x003b1;4 subunit of the neuronal nicotinic acetylcholine receptor (nAChR); associated with type 1 ADNFLE</div></li><li class="half_rhythm"><div><b><i>CHRNB2</i>,</b> encoding the &#x003b2;2 subunit of the nAChR; associated with type 3 ADNFLE</div></li><li class="half_rhythm"><div><b><i>CHRNA2</i>,</b> encoding &#x003b1;2 subunit of the nAChR; associated with type 4 ADNFLE</div></li></ul><div class="half_rhythm">The neuronal nicotinic acetylcholine receptor is a heterologous pentamer comprising various combinations of alpha and beta subunits, encoded by <i>CHRNA2-CHRNA7</i> and <i>CHRNB2-CHRNB4</i>, respectively. The most common configuration in thalamus and isocortex is (&#x003b1;4)<sub>2</sub>(&#x003b2;2)<sub>3</sub> subunits (i.e., 2 &#x003b1;4 and 3 &#x003b2;2 subunits).</div><div class="half_rhythm">The receptor is widely distributed in the brain, including the frontal lobes. It is thought that the receptor is a presynaptic modulator of other neurotransmitter systems including gamma-amino butyric acid (GABA), glutamate, and dopamine, and therefore may have variable effects on excitatory and inhibitory pathways [<a class="bk_pop" href="#adnfle.REF.kuryatov.1997.9035">Kuryatov et al 1997</a>, <a class="bk_pop" href="#adnfle.REF.bertrand.1999.457">Bertrand 1999</a>, <a class="bk_pop" href="#adnfle.REF.buisson.1999">Buisson et al 1999</a>, <a class="bk_pop" href="#adnfle.REF.picard.1999.1198">Picard et al 1999</a>].</div><div class="half_rhythm">The second transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the receptor forms the ion channel pore and is the site of most of the pathogenic variants implicated in ADNFLE. Pathogenic variants in <i>CHRNA4</i> and <i>CHRNB2</i> associated with ADNFLE occur in highly conserved amino acids and alter the function of the resulting receptors.</div><div class="half_rhythm">Functional studies of different pathogenic variants provide conflicting results, although an increase in acetylcholine (Ach) sensitivity in vitro is typical for known ADNFLE-associated pathogenic variants [<a class="bk_pop" href="#adnfle.REF.kuryatov.1997.9035">Kuryatov et al 1997</a>, <a class="bk_pop" href="#adnfle.REF.steinlein.1997.943">Steinlein et al 1997</a>, <a class="bk_pop" href="#adnfle.REF.bertrand.1998.751">Bertrand et al 1998</a>, <a class="bk_pop" href="#adnfle.REF.bertrand.1999.457">Bertrand 1999</a>, <a class="bk_pop" href="#adnfle.REF.de_fusco.2000.275">De Fusco et al 2000</a>, <a class="bk_pop" href="#adnfle.REF.phillips.2001.225">Phillips et al 2001</a>, <a class="bk_pop" href="#adnfle.REF.di_corcia.2005.59">di Corcia et al 2005</a>]; thus, the mechanism whereby the pathogenic variants cause ADNFLE is poorly understood.</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>KCNT1</i>,</b> encoding a sodium-activated potassium channel; associated with type 5 ADNFLE. Sodium-activated potassium channel encoded by <i>KCNT1</i> is widely distributed in many regions of the mammalian brain, including the frontal cortex. Its activity contributes to the slow hyperpolarization that follows repetitive firing.</div><div class="half_rhythm">Mutated channels with pathogenic variants identified in ADNFLE produce voltage-activated currents with higher magnitude compared to wild type, leading to gain of function.</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>DEPDC5</i>,</b> encoding <i>d</i>ishevelled, <i>e</i>gl-10, and <i>p</i>leckstrin (DEP) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing protein 5. DEPDC5 is a component of GATOR1 (<i>G</i>TPase-activating protein [GAP] <i>a</i>ctivity <i>to</i>ward <i>R</i>AGs complex 1), which negatively regulates mTORC1 (<i>m</i>ammalian <i>t</i>arget <i>o</i>f <i>r</i>apamycin <i>c</i>omplex 1) and is expressed ubiquitously in human tissues. Most pathogenic variants are truncating variants that can be expected to result in <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> degradation.</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>CRH</i>,</b> encoding corticotropin-releasing hormone (CRH). CRH is widely distributed throughout the central nervous system; it acts as a neurotransmitter or neuromodulator in extrahypothalamic circuits to integrate a multisystem response to stress that controls numerous behaviors including sleep and arousal. Variations in the promoter [<a class="bk_pop" href="#adnfle.REF.combi.2005.899">Combi et al 2005</a>] or in the pro-sequence region [<a class="bk_pop" href="#adnfle.REF.sansoni.2013.e61306">Sansoni et al 2013</a>] have been reported. The variant identified in one family with ADNFLE decreases peptide secretion in vitro [<a class="bk_pop" href="#adnfle.REF.sansoni.2013.e61306">Sansoni et al 2013</a>].</div></li></ul><div id="adnfle.CHRNA2"><h4><i>CHRNA2</i></h4><p><b>Gene structure.</b>
<i>CHRNA2</i> has seven exons distributed over ~19 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1169/#adnfle.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Benign variants have been described [<a class="bk_pop" href="#adnfle.REF.weiland.1996.433">Weiland &#x00026; Steinlein 1996</a>, <a class="bk_pop" href="#adnfle.REF.phillips.1997.135">Phillips &#x00026; Mulley 1997</a>].</p><p><b>Pathogenic variants.</b> One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulting in changes in the highly conserved region of the first transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> has been described [<a class="bk_pop" href="#adnfle.REF.aridon.2006.342">Aridon et al 2006</a>]. See <a class="figpopup" href="/books/NBK1169/table/adnfle.T.selected_chrna2_pathogenic_vari/?report=objectonly" target="object" rid-figpopup="figadnfleTselectedchrna2pathogenicvari" rid-ob="figobadnfleTselectedchrna2pathogenicvari">Table 2</a>.</p><div id="adnfle.T.selected_chrna2_pathogenic_vari" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>CHRNA2</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1169/table/adnfle.T.selected_chrna2_pathogenic_vari/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adnfle.T.selected_chrna2_pathogenic_vari_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.836T&#x0003e;A</td><td headers="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile279Asn&#x000a0;<sup>1</sup></td><td headers="hd_h_adnfle.T.selected_chrna2_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/157074211" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000742<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/153792669" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000733<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="adnfle.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.aridon.2006.342">Aridon et al [2006]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CHRNA2</i> encodes the &#x003b1;2 subunit of nAChR. The &#x003b1;2 subunit is composed of 529 amino acids. <i>CHRNA2</i> is one of the subunits that form functional nAChRs.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>CHRNA2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> increases the receptor sensitivity to acetylcholine, and gain of function of nAChR may be a contributing mechanism in the development of ADNFLE [<a class="bk_pop" href="#adnfle.REF.aridon.2006.342">Aridon et al 2006</a>, <a class="bk_pop" href="#adnfle.REF.hoda.2009.1599">Hoda et al 2009</a>]. Carbamazepine and oxcarbazepine produce a non-competitive channel inhibition in heteromeric neuronal nicotinic receptors including mutated &#x003b1;2 subunits as well as wild type &#x003b1;2 subunits, but the different heteromeric nicotinic receptors exhibit distinct pharmacologic properties [<a class="bk_pop" href="#adnfle.REF.di_resta.2010.13">Di Resta et al 2010</a>].</p></div><div id="adnfle.CHRNA4"><h4><i>CHRNA4</i></h4><p><b>Gene structure.</b>
<i>CHRNA4</i> has six exons distributed over ~17 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA [<a class="bk_pop" href="#adnfle.REF.steinlein.1996.289">Steinlein et al 1996</a>]. The main part of the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> is distributed in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5 [<a class="bk_pop" href="#adnfle.REF.steinlein.1996.289">Steinlein et al 1996</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1169/#adnfle.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Benign variants have been described [<a class="bk_pop" href="#adnfle.REF.weiland.1996.433">Weiland &#x00026; Steinlein 1996</a>, <a class="bk_pop" href="#adnfle.REF.phillips.1997.135">Phillips &#x00026; Mulley 1997</a>].</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK1169/table/adnfle.T.chrna4_pathogenic_variants_disc/?report=objectonly" target="object" rid-figpopup="figadnfleTchrna4pathogenicvariantsdisc" rid-ob="figobadnfleTchrna4pathogenicvariantsdisc">Table 3</a>. In one case of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> NFLE <a class="bk_pop" href="#adnfle.REF.chen.2009.152">Chen et al [2009]</a> identified a novel variant in <i>CHRNA4</i> that causes an &#x003b1;4-Arg336His amino acid exchange outside the transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, and in the second intracellular loop between the third and fourth transmembrane domains. Instances of the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurring independently in multiple countries have been reported [<a class="bk_pop" href="#adnfle.REF.steinlein.2000.529">Steinlein et al 2000</a>, <a class="bk_pop" href="#adnfle.REF.hwang.2011.609">Hwang et al 2011</a>].</p><div id="adnfle.T.chrna4_pathogenic_variants_disc" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>CHRNA4</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1169/table/adnfle.T.chrna4_pathogenic_variants_disc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adnfle.T.chrna4_pathogenic_variants_disc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.851C&#x0003e;T</td><td headers="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser284Leu&#x000a0;<sup>1</sup></td><td headers="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/188035859" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000744<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="/protein/4502827" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000735<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1007G&#x0003e;A</td><td headers="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg336His&#x000a0;<sup>2</sup></td><td headers="hd_h_adnfle.T.chrna4_pathogenic_variants_disc_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="adnfle.TF.3.1"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.hirose.1999.1749">Hirose et al [1999]</a>, <a class="bk_pop" href="#adnfle.REF.rozycka.2003.1113">Rozycka et al [2003]</a></p></div></dd><dt>2. </dt><dd><div id="adnfle.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.chen.2009.152">Chen et al [2009]</a></p></div></dd></dl></div></div></div><p>For more information, see <a href="/books/NBK1169/#adnfle.molgen.TA">Table A</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Each nicotinic acetylcholine receptor subunit has a conserved N-terminal extracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region [<a class="bk_pop" href="#adnfle.REF.elliott.1996.217">Elliott et al 1996</a>]. The &#x003b1; subunits are characterized by the presence of a pair of cysteine residues (Cys161 and Cys175, <a href="/protein/4502827" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000735.1</a>) that are presumed to function as part of the ACh binding site when the &#x003b1;4 subunits are complexed as a heterologous pentamer with the &#x003b2; subunits [<a class="bk_pop" href="#adnfle.REF.figl.1998.655">Figl et al 1998</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Functional studies of different pathogenic variants provide conflicting results, although an increase in ACh sensitivity in vitro is typical for known ADNFLE-causing pathogenic variants [<a class="bk_pop" href="#adnfle.REF.kuryatov.1997.9035">Kuryatov et al 1997</a>, <a class="bk_pop" href="#adnfle.REF.steinlein.1997.943">Steinlein et al 1997</a>, <a class="bk_pop" href="#adnfle.REF.bertrand.1998.751">Bertrand et al 1998</a>, <a class="bk_pop" href="#adnfle.REF.bertrand.1999.457">Bertrand 1999</a>, <a class="bk_pop" href="#adnfle.REF.de_fusco.2000.275">De Fusco et al 2000</a>, <a class="bk_pop" href="#adnfle.REF.phillips.2001.225">Phillips et al 2001</a>]; hence gain of function of nAChR may be a contributing mechanism in the development of ADNFLE. Studies on mutated nAchR demonstrated an increased sensitivity to carbamazepine [<a class="bk_pop" href="#adnfle.REF.picard.1999.1198">Picard et al 1999</a>].</p></div><div id="adnfle.CHRNB2"><h4><i>CHRNB2</i></h4><p><b>Gene structure.</b>
<i>CHRNB2</i> has six exons distributed over ~12 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. The main part of the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> is distributed in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1169/#adnfle.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Benign variants of the <i>CHRN</i> receptor genes have been described [<a class="bk_pop" href="#adnfle.REF.weiland.1996.433">Weiland &#x00026; Steinlein 1996</a>, <a class="bk_pop" href="#adnfle.REF.phillips.1997.135">Phillips &#x00026; Mulley 1997</a>].</p><p><b>Pathogenic variants.</b> Various pathogenic variants resulting in changes in the highly conserved region of the conducting pore or transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> are described. A novel variant in <i>CHRNB2</i> located between transmembrane domains M3 and M4 was identified in a <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> NFLE case [<a class="bk_pop" href="#adnfle.REF.liu.2011.94">Liu et al 2011</a>].</p><p>For more information, see <a href="/books/NBK1169/#adnfle.molgen.TA">Table A</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CHRNB2</i> encodes the &#x003b2;2 subunit of nAChR. The &#x003b2;2 subunit is composed of 503 amino acids. <i>CHRNB2</i> is similar to <i>CHRNA4</i>, but the &#x003b2; subunits encoded by the genes are defined by the lack of paired cysteine residues [<a class="bk_pop" href="#adnfle.REF.elliott.1996.217">Elliott et al 1996</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Functional studies of different pathogenic variants provide conflicting results, although an increase in ACh sensitivity in vitro is typical for known ADNFLE-associated pathogenic variants [<a class="bk_pop" href="#adnfle.REF.kuryatov.1997.9035">Kuryatov et al 1997</a>, <a class="bk_pop" href="#adnfle.REF.steinlein.1997.943">Steinlein et al 1997</a>, <a class="bk_pop" href="#adnfle.REF.bertrand.1998.751">Bertrand et al 1998</a>, <a class="bk_pop" href="#adnfle.REF.bertrand.1999.457">Bertrand 1999</a>, <a class="bk_pop" href="#adnfle.REF.de_fusco.2000.275">De Fusco et al 2000</a>, <a class="bk_pop" href="#adnfle.REF.phillips.2001.225">Phillips et al 2001</a>]; hence, gain of function of nAChR may be a contributing mechanism in the development of ADNFLE.</p></div><div id="adnfle.CRH"><h4><i>CRH</i></h4><p><b>Gene.</b>
<i>CRH</i> has two exons; the first one is noncoding (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000756.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000756.3</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1169/#adnfle.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Benign variants have been described [<a class="bk_pop" href="#adnfle.REF.shimmin.2007.434">Shimmin et al 2007</a>].</p><p><b>Pathogenic variants.</b> Two variants in the <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> and one <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant have been reported [<a class="bk_pop" href="#adnfle.REF.combi.2005.899">Combi et al 2005</a>, <a class="bk_pop" href="#adnfle.REF.sansoni.2013.e61306">Sansoni et al 2013</a>]. See <a class="figpopup" href="/books/NBK1169/table/adnfle.T.selected_crh_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figadnfleTselectedcrhpathogenicvariant" rid-ob="figobadnfleTselectedcrhpathogenicvariant">Table 4</a>.</p><div id="adnfle.T.selected_crh_pathogenic_variant" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>CRH</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1169/table/adnfle.T.selected_crh_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adnfle.T.selected_crh_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-365G&#x0003e;C&#x000a0;<sup>1</sup></td><td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None&#x000a0;<sup>2</sup></td><td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000756.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000756<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-669C&#x0003e;A&#x000a0;<sup>3</sup></td><td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.89C&#x0003e;G</td><td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro30Arg&#x000a0;<sup>4</sup></td><td headers="hd_h_adnfle.T.selected_crh_pathogenic_variant_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000756.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000756<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_000747.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000747<wbr style="display:inline-block"></wbr>​.1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="adnfle.TF.4.1"><p class="no_margin"><a href="/nuccore/224589820" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NC_000008<wbr style="display:inline-block"></wbr>​.10</a>:g.67090878C&#x0003e;G (GRCh37); <a href="/projects/SNP/snp_ref.cgi?rs=72556399" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs72556399</a></p></div></dd><dt>2. </dt><dd><div id="adnfle.TF.4.2"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.combi.2005.899">Combi et al [2005]</a></p></div></dd><dt>3. </dt><dd><div id="adnfle.TF.4.3"><p class="no_margin"><a href="/nuccore/224589820" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NC_000008<wbr style="display:inline-block"></wbr>​.10</a>:g.67091182G&#x0003e;T (GRCh37); <a href="/projects/SNP/snp_ref.cgi?rs=12721510" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs12721510</a></p></div></dd><dt>4. </dt><dd><div id="adnfle.TF.4.4"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.sansoni.2013.e61306">Sansoni et al [2013]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<a href="http://www.uniprot.org/uniprot/P06850" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Corticoliberin</a> is composed of 196 amino acids.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> In vitro assays demonstrated that the pathogenic variants result in altered levels of gene expression. The luciferase assay showed stronger promoter activity for the c.-669C&#x0003e;A variation, whereas reduction of the promoter activity was detected for the c.-365G&#x0003e;C <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#adnfle.REF.combi.2005.899">Combi et al 2005</a>].</p></div><div id="adnfle.DEPDC5"><h4><i>DEPDC5</i></h4><p><b>Gene structure.</b>
<i>DEPDC5</i> has 43 exons distributed over ~150 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1169/#adnfle.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of the <i>DEPDC5</i> pathogenic variants detected resulted in premature termination, suggesting <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> as the disease mechanism.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> DEPDC5 is composed of 1,603 amino acids and is expressed ubiquitously in human tissues [<a class="bk_pop" href="#adnfle.REF.dibbens.2013.546">Dibbens et al 2013</a>]. It contains a DEP homology <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that is present in many proteins of G-protein signaling pathways. DEPDC5 is a component of GATOR1 (GTPase-activating protein [GAP] activity toward RAGs complex 1), which negatively regulates mTORC1 (mammalian target of rapamycin complex 1) [<a class="bk_pop" href="#adnfle.REF.barpeled.2013.1100">Bar-Peled et al 2013</a>]. The mTOR pathway plays a role in many activities including cell growth, cell proliferation, and metabolism.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most pathogenic variants are truncating variants that can be expected to result in <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> degradation. Aberrant mTORC1 signaling is known to cause disturbance in neuronal migration and cortical lamination, which has been demonstrated in neuronal migration disorders including <a href="/books/n/gene/tuberous-sclerosis/">tuberous sclerosis</a>. Pathogenic variants in <i>DEPDC5</i> appear to have a less dramatic effect on mTORC1 signaling but disturb it sufficiently to cause focal epilepsy. Indeed, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of individuals with <i>DEPDC5</i> pathogenic variants extends with the identification of variants associated with rolandic epilepsy, unclassified focal epilepsy [<a class="bk_pop" href="#adnfle.REF.lal.2014.788">Lal et al 2014</a>], and focal epilepsy with brain malformations [<a class="bk_pop" href="#adnfle.REF.scheffer.2014.782">Scheffer et al 2014</a>].</p></div><div id="adnfle.KCNT1"><h4><i>KCNT1</i></h4><p><b>Gene structure.</b>
<i>KCNT1</i> has 31 exons distributed over ~90 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. There are two relevant transcript variants (the longer <a href="/nuccore/NM_020822.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020822.2</a> and the alternate <a href="/nuccore/NM_001272003.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001272003.1</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1169/#adnfle.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Various pathogenic variants resulting in changes in the highly conserved region are described. All of the variants are located within the intracellular region and most alter amino acids within or immediately adjacent to a nicotinamide adenine dinucleotide (NAD+)-binding site. They are identified in Australian (of British heritage), Italian, and Israeli families. See <a class="figpopup" href="/books/NBK1169/table/adnfle.T.selected_kcnt1_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figadnfleTselectedkcnt1pathogenicvaria" rid-ob="figobadnfleTselectedkcnt1pathogenicvaria">Table 5</a>.</p><div id="adnfle.T.selected_kcnt1_pathogenic_varia" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Selected <i>KCNT1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1169/table/adnfle.T.selected_kcnt1_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__adnfle.T.selected_kcnt1_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1193G&#x0003e;A</td><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg398Gln&#x000a0;<sup>1</sup></td><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_020822.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020822<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_065873.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_065873<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2386T&#x0003e;C</td><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr796His&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2688G&#x0003e;A</td><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met896Ile&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2782C&#x0003e;T</td><td headers="hd_h_adnfle.T.selected_kcnt1_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg928Cys&#x000a0;<sup>1</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="adnfle.TF.5.1"><p class="no_margin"><a class="bk_pop" href="#adnfle.REF.heron.2012.1188">Heron et al [2012]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>KCNT1</i> (previously known as <i>SLACK</i>, <i>SLO2.2</i>, and <i>KCa4.1</i>) encodes a sodium-activated potassium channel and is composed of 1,235 amino acids [<a class="bk_pop" href="#adnfle.REF.joiner.1998.462">Joiner et al 1998</a>]. KCNT1 channel contains six putative membrane-spanning regions and extended C-terminus. The C-terminal cytoplasmic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> contains several motifs believed to interact with a protein network. One of the proteins is fragile X mental retardation protein (FMRP), a potent stimulator of <i>KCNT1</i> channel activity [<a class="bk_pop" href="#adnfle.REF.brown.2010.819">Brown et al 2010</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The electrophysiologic properties of <i>KCNT1</i> variants identified in patients with ADNFLE were analyzed in vitro [<a class="bk_pop" href="#adnfle.REF.milligan.2014.581">Milligan et al 2014</a>]. All of the variants studied (see <a class="figpopup" href="/books/NBK1169/table/adnfle.T.selected_kcnt1_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figadnfleTselectedkcnt1pathogenicvaria" rid-ob="figobadnfleTselectedkcnt1pathogenicvaria">Table 5</a>) increase current magnitude leading to gain of function, and in some cases hasten (p.Met896Ile, p.Arg928Cys) or slow (p.Arg398Gln) activation. The mechanisms underlying increased neuronal excitability due to a gain of function of the KCNT1 channels are not known.</p></div></div></div><div id="adnfle.References"><h2 id="_adnfle_References_">References</h2><div id="adnfle.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF1">American Academy of Sleep Medicine. The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. Available <a href="http://vct.iums.ac.ir/uploads/icsd.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2001. Accessed 3-13-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.aridon.2006.342">Aridon P, Marini C, Di Resta C, Brilli E, De Fusco M, Politi F, Parrini E, Manfredi I, Pisano T, Pruna D, Curia G, Cianchetti C, Pasqualetti M, Becchetti A, Guerrini R, Casari G. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:342–50.</span> [<a href="/pmc/articles/PMC1559502/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1559502</span></a>] [<a href="/pubmed/16826524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16826524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.barpeled.2013.1100">Bar-Peled L, Chantranupong L, Cherniack AD, Chen W W, Ottina KA, Grabiner BC, Spear ED, Carter SL, Meyerson M, Sabatini DM. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. <span><span class="ref-journal">Science. </span>2013;<span class="ref-vol">340</span>:1100–6.</span> [<a href="/pmc/articles/PMC3728654/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3728654</span></a>] [<a href="/pubmed/23723238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23723238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.bearden.2014.457">Bearden D, Strong A, Ehnot J, DiGiovine M, Dlugos D, Goldberg EM. Targeted treatment of migrating partial seizures of infancy with quinidine. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">76</span>:457–61.</span> [<a href="/pubmed/25042079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25042079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.bertrand.1999.457">Bertrand D. Neuronal nicotinic acetylcholine receptors: their properties and alterations in autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Rev Neurol (Paris). </span>1999;<span class="ref-vol">155</span>:457–62.</span> [<a href="/pubmed/10472659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10472659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.bertrand.1998.751">Bertrand S, Weiland S, Berkovic SF, Steinlein OK, Bertrand D. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Br J Pharmacol. </span>1998;<span class="ref-vol">125</span>:751–60.</span> [<a href="/pmc/articles/PMC1571006/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1571006</span></a>] [<a href="/pubmed/9831911" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9831911</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.brown.2010.819">Brown MR, Kronengold J, Gazula VR, Chen Y, Strumbos JG, Sigworth FJ, Navaratnam D, Kaczmarek LK. Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack. <span><span class="ref-journal">Nat Neurosci. </span>2010;<span class="ref-vol">13</span>:819–21.</span> [<a href="/pmc/articles/PMC2893252/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2893252</span></a>] [<a href="/pubmed/20512134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20512134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.buisson.1999">Buisson B, Curtis L, Betrand D. Neuronal nicotinic acetylcholine receptor and epilepsy. In: Berkovic SF, Genton P, Hirsch E, Picard F, eds. <em>Genetics of Focal Epilepsies.</em> London, UK: John Libbey &#x00026; Co; 1999:187-202.</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.carre_o.2010.155">Carre&#x000f1;o M, Garcia-Alvarez D, Maestro I, Fern&#x000e1;ndez S, Donaire A, Boget T, Rumi&#x000e0; J, Pintor L, Setoain X. Malignant autosomal dominant frontal lobe epilepsy with repeated episodes of status epilepticus: successful treatment with vagal nerve stimulation. <span><span class="ref-journal">Epileptic Disord. </span>2010;<span class="ref-vol">12</span>:155–8.</span> [<a href="/pubmed/20478764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20478764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.chen.2009.152">Chen Y, Wu L, Fang Y, He Z, Peng B, Shen Y, Xu Q. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Epilepsy Res. </span>2009;<span class="ref-vol">83</span>:152–6.</span> [<a href="/pubmed/19058950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19058950</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.cho.2003.1625">Cho YW, Motamedi GK, Laufenberg I, Sohn SI, Lim JG, Lee H, Yi SD, Lee JH, Kim DK, Reba R, Gaillard WD, Theodore WH, Lesser RP, Steinlein OK. A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:1625–32.</span> [<a href="/pubmed/14623738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14623738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.combi.2005.899">Combi R, Dalpra L, Ferini-Strambi L, Tenchini ML. Frontal lobe epilepsy and mutations of the corticotropin-releasing hormone gene. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">58</span>:899–904.</span> [<a href="/pubmed/16222669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16222669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.combi.2004.923">Combi R, Dalpra L, Tenchini ML, Ferini-Strambi L. Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview. <span><span class="ref-journal">J Neurol. </span>2004;<span class="ref-vol">251</span>:923–34.</span> [<a href="/pubmed/15316796" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15316796</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.conti.2015.1520">Conti V, Aracri P, Chiti L, Brusco S, Mari F, Marini C, Albanese M, Marchi A, Liguori C, Placidi F, Romigi A, Becchetti A, Guerrini R. Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:1520–8.</span> [<a href="/pmc/articles/PMC4408286/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4408286</span></a>] [<a href="/pubmed/25770198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25770198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.de_fusco.2000.275">De Fusco M, Becchetti A, Patrignani A, Annesi G, Gambardella A, Quattrone A, Ballabio A, Wanke E, Casari G. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">26</span>:275–6.</span> [<a href="/pubmed/11062464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11062464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.dibbens.2013.546">Dibbens LM, de Vries B, Donatello S, Heron SE, Hodgson BL, Chintawar S, Crompton DE, Hughes JN, Bellows ST, Klein KM, Callenbach PM, Corbett MA, Gardner AE, Kivity S, Iona X, Regan BM, Weller CM, Crimmins D, O'Brien TJ, Guerrero-Lopez R, Mulley JC, Dubeau F, Licchetta L, Bisulli F, Cossette P, Thomas PQ, Gecz J, Serratosa J, Brouwer OF, Andermann F, Andermann E, van den Maagdenberg AM, Pandolfo M, Berkovic SF, Scheffer IE. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:546–51.</span> [<a href="/pubmed/23542697" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23542697</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.di_corcia.2005.59">di Corcia G, Blasetti A, De Simone M, Verrotti A, Chiarelli F. Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: understanding the nicotinic acetylcholine receptor (nAChR). <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2005;<span class="ref-vol">9</span>:59–66.</span> [<a href="/pubmed/15843070" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15843070</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.di_resta.2010.13">Di Resta C, Ambrosi P, Curia G, Becchetti A. Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Eur J Pharmacol. </span>2010;<span class="ref-vol">643</span>:13–20.</span> [<a href="/pubmed/20561518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20561518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.el_helou.2008.2201">El Helou J, Navarro V, Depienne C, Fedirko E, LeGuern E, Baulac M, An-Gourfinkel I, Adam C. K-complex-induced seizures in autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Clin Neurophysiol. </span>2008;<span class="ref-vol">119</span>:2201–4.</span> [<a href="/pubmed/18762450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18762450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.elliott.1996.217">Elliott KJ, Ellis SB, Berckhan KJ, Urrutia A, Chavez-Noriega LE, Johnson EC, Velicelebi G, Harpold MM. Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits. <span><span class="ref-journal">J Mol Neurosci. </span>1996;<span class="ref-vol">7</span>:217–28.</span> [<a href="/pubmed/8906617" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8906617</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.ferinistrambi.2012.343">Ferini-Strambi L, Sansoni V, Combi R. Nocturnal frontal lobe epilepsy and the acetylcholine receptor. <span><span class="ref-journal">Neurologist. </span>2012;<span class="ref-vol">18</span>:343–9.</span> [<a href="/pubmed/23114665" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23114665</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.figl.1998.655">Figl A, Viseshakul N, Shafaee N, Forsayeth J, Cohen BN. Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response. <span><span class="ref-journal">J Physiol. </span>1998;<span class="ref-vol">513</span>:655–70.</span> [<a href="/pmc/articles/PMC2231326/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2231326</span></a>] [<a href="/pubmed/9824708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9824708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.hayman.1997.969">Hayman M, Scheffer IE, Chinvarun Y, Berlangieri SU, Berkovic SF. Autosomal dominant nocturnal frontal lobe epilepsy: demonstration of focal frontal onset and intrafamilial variation. <span><span class="ref-journal">Neurology. </span>1997;<span class="ref-vol">49</span>:969–75.</span> [<a href="/pubmed/9339675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9339675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.heron.2012.1188">Heron SE, Smith KR, Bahlo M, Nobili L, Kahana E, Licchetta L, Oliver KL, Mazarib A, Afawi Z, Korczyn A, Plazzi G, Petrou S, Berkovic SF, Scheffer IE, Dibbens LM. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1188–90.</span> [<a href="/pubmed/23086396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23086396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.hirose.1999.1749">Hirose S, Iwata H, Akiyoshi H, Kobayashi K, Ito M, Wada K, Kaneko S, Mitsudome A. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">53</span>:1749–53.</span> [<a href="/pubmed/10563623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10563623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.hoda.2009.1599">Hoda JC, Wanischeck M, Bertrand D, Steinlein OK. Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene. <span><span class="ref-journal">FEBS Lett. </span>2009;<span class="ref-vol">583</span>:1599–604.</span> [<a href="/pubmed/19383498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19383498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.hwang.2011.609">Hwang SK, Makita Y, Kurahashi H, Cho YW, Hirose S. Autosomal dominant nocturnal frontal lobe epilepsy: a genotypic comparative study of Japanese and Korean families carrying the CHRNA4 Ser284Leu mutation. <span><span class="ref-journal">J Hum Genet. </span>2011;<span class="ref-vol">56</span>:609–12.</span> [<a href="/pubmed/21753767" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21753767</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.ito.2000.52">Ito M, Kobayashi K, Fujii T, Okuno T, Hirose S, Iwata H, Mitsudome A, Kaneko S. Electroclinical picture of autosomal dominant nocturnal frontal lobe epilepsy in a Japanese family. <span><span class="ref-journal">Epilepsia. </span>2000;<span class="ref-vol">41</span>:52–8.</span> [<a href="/pubmed/10643924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10643924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.joiner.1998.462">Joiner WJ, Tang MD, Wang LY, Dworetzky SI, Boissard CG, Gan L, Gribkoff VK, Kaczmarek LK. Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits. <span><span class="ref-journal">Nat Neurosci. </span>1998;<span class="ref-vol">1</span>:462–9.</span> [<a href="/pubmed/10196543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10196543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.khatami.1998.809">Khatami R, Neumann M, Schulz H, Kolmel HW. A family with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation. <span><span class="ref-journal">J Neurol. </span>1998;<span class="ref-vol">245</span>:809–10.</span> [<a href="/pubmed/9840354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9840354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.kuryatov.1997.9035">Kuryatov A, Gerzanich V, Nelson M, Olale F, Lindstrom J. Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. <span><span class="ref-journal">J Neurosci. </span>1997;<span class="ref-vol">17</span>:9035–47.</span> [<a href="/pmc/articles/PMC6573611/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6573611</span></a>] [<a href="/pubmed/9364050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9364050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.lal.2014.788">Lal D, Reinthaler EM, Schubert J, Muhle H, Riesch E, Kluger G, Jabbari K, Kawalia A, Baumel C, Holthausen H, Hahn A, Feucht M, Neophytou B, Haberlandt E, Becker F, Altmuller J, Thiele H, Lemke JR, Lerche H, Nurnberg P, Sander T, Weber Y, Zimprich F, Neubauer BA. DEPDC5 mutations in genetic focal epilepsies of childhood. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">75</span>:788–92.</span> [<a href="/pubmed/24591017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24591017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.liu.2011.94">Liu H, Lu C, Li Z, Zhou S, Li X, Ji L, Lu Q, Lv R, Wu L, Ma X. The identification of a novel mutation of nicotinic acetylcholine receptor gene CHRNB2 in a Chinese patient: Its possible implication in non-familial nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Epilepsy Res. </span>2011;<span class="ref-vol">95</span>:94–9.</span> [<a href="/pubmed/21497487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21497487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.magnusson.2003.91">Magnusson A, Stordal E, Brodtkorb E, Steinlein O. Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations. <span><span class="ref-journal">Psychiatr Genet. </span>2003;<span class="ref-vol">13</span>:91–5.</span> [<a href="/pubmed/12782965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12782965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.milligan.2014.581">Milligan CJ, Li M, Gazina EV, Heron SE, Nair U, Trager C, Reid CA, Venkat A, Younkin DP, Dlugos DJ, Petrovski S, Goldstein DB, Dibbens LM, Scheffer IE, Berkovic SF, Petrou S. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">75</span>:581–90.</span> [<a href="/pmc/articles/PMC4158617/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4158617</span></a>] [<a href="/pubmed/24591078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24591078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.nakken.1999.88">Nakken KO, Magnusson A, Steinlein OK. Autosomal dominant nocturnal frontal lobe epilepsy: an electroclinical study of a Norwegian family with ten affected members. <span><span class="ref-journal">Epilepsia. </span>1999;<span class="ref-vol">40</span>:88–92.</span> [<a href="/pubmed/9924907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9924907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.oldani.1996.964">Oldani A, Zucconi M, Ferini-Strambi L, Bizzozero D, Smirne S. Autosomal dominant nocturnal frontal lobe epilepsy: electroclinical picture. <span><span class="ref-journal">Epilepsia. </span>1996;<span class="ref-vol">37</span>:964–76.</span> [<a href="/pubmed/8822695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8822695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.phillips.2001.225">Phillips HA, Favre I, Kirkpatrick M, Zuberi SM, Goudie D, Heron SE, Scheffer IE, Sutherland GR, Berkovic SF, Bertrand D, Mulley JC. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:225–31.</span> [<a href="/pmc/articles/PMC1234917/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1234917</span></a>] [<a href="/pubmed/11104662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11104662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.phillips.2000.264">Phillips HA, Marini C, Scheffer IE, Sutherland GR, Mulley JC, Berkovic SF. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">48</span>:264–7.</span> [<a href="/pubmed/10939581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10939581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.phillips.1997.135">Phillips HA, Mulley JC. SSCP variants within the alpha 4 subunit of the neuronal nicotinic acetylcholine receptor gene. <span><span class="ref-journal">Clin Genet. </span>1997;<span class="ref-vol">51</span>:135–6.</span> [<a href="/pubmed/9112007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9112007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.phillips.1998.1108">Phillips HA, Scheffer IE, Crossland KM, Bhatia KP, Fish DR, Marsden CD, Howell SJ, Stephenson JB, Tolmie J, Plazzi G, Eeg-Olofsson O, Singh R, Lopes-Cendes I, Andermann E, Andermann F, Berkovic SF, Mulley JC. Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:1108–16.</span> [<a href="/pmc/articles/PMC1377480/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377480</span></a>] [<a href="/pubmed/9758605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9758605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.picard.2000.1247">Picard F, Baulac S, Kahane P, Hirsch E, Sebastianelli R, Thomas P, Vigevano F, Genton P, Guerrini R, Gericke CA, An I, Rudolf G, Herman A, Brice A, Marescaux C, LeGuern E. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. <span><span class="ref-journal">Brain. </span>2000;<span class="ref-vol">123</span>:1247–62.</span> [<a href="/pubmed/10825362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10825362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.picard.1999.1198">Picard F, Bertrand S, Steinlein OK, Bertrand D. Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine. <span><span class="ref-journal">Epilepsia. </span>1999;<span class="ref-vol">40</span>:1198–209.</span> [<a href="/pubmed/10487182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10487182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.picard.2007">Picard F, Brodtkorb E. Familial frontal lobe epilepsies. In: Engel J, Pedley TA, eds. <em>Epilepsy: A Comprehensive Textbook</em>. 2 ed. Philadelphia, PA: Lippincott Williams &#x00026; Wilkins; 2007:2495-502.</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.picard.2014.2101">Picard F, Makrythanasis P, Navarro V, Ishida S, de Bellescize J, Ville D, Weckhuysen S, Fosselle E, Suls A, De Jonghe P, Vasselon Raina M, Lesca G, Depienne C, An-Gourfinkel I, Vlaicu M, Baulac M, Mundwiller E, Couarch P, Combi R, Ferini-Strambi L, Gambardella A, Antonarakis SE, Leguern E, Steinlein O, Baulac S. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:2101–6.</span> [<a href="/pubmed/24814846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24814846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.picard.2009.354">Picard F, Pegna AJ, Arntsberg V, Lucas N, Kaczmarek I, Todica O, Chiriaco C, Seeck M, Brodtkorb E. Neuropsychological disturbances in frontal lobe epilepsy due to mutated nicotinic receptors. <span><span class="ref-journal">Epilepsy Behav. </span>2009;<span class="ref-vol">14</span>:354–9.</span> [<a href="/pubmed/19059498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19059498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.picard.2012">Picard F, Scheffer IE. Genetically determined focal epilepsies. In: Bureau M, Genton P, Dravet C, Delgado-Escueta AV, Tassinari CA, Thomas P, Wolf P, eds. <em>Epileptic Syndromes in Infancy, Childhood and Adolescence.</em> 5 ed. Montrouge, France: John Libbey Eurotext; 2012:354-9.</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.provini.1999.1017">Provini F, Plazzi G, Tinuper P, Vandi S, Lugaresi E, Montagna P. Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. <span><span class="ref-journal">Brain. </span>1999;<span class="ref-vol">122</span>:1017–31.</span> [<a href="/pubmed/10356056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10356056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.puligheddu.2017.1762">Puligheddu M, Melis M, Pillolla G, Milioli G, Parrino L, Terzano GM, Aroni S, Sagheddu C, Marrosu F, Pistis M, Muntoni AL. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Epilepsia. </span>2017;<span class="ref-vol">58</span>:1762–70.</span> [<a href="/pubmed/28766701" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28766701</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.rozycka.2003.1113">Rozycka A, Skorupska E, Kostyrko A, Trzeciak WH. Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Epilepsia. </span>2003;<span class="ref-vol">44</span>:1113–7.</span> [<a href="/pubmed/12887446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12887446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.sansoni.2013.e61306">Sansoni V, Forcella M, Mozzi A, Fusi P, Ambrosini R, Ferini-Strambi L, Combi R. Functional characterization of a CRH missense mutation identified in an ADNFLE family. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e61306.</span> [<a href="/pmc/articles/PMC3623861/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3623861</span></a>] [<a href="/pubmed/23593457" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23593457</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.scheffer.2014.782">Scheffer IE, Heron SE, Regan BM, Mandelstam S, Crompton DE, Hodgson BL, Licchetta L, Provini F, Bisulli F, Vadlamudi L, Gecz J, Connelly A, Tinuper P, Ricos MG, Berkovic SF, Dibbens LM. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">75</span>:782–7.</span> [<a href="/pubmed/24585383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24585383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.schenck.2000.145">Schenck CH, Mahowald MW. Parasomnias. Managing bizarre sleep-related behavior disorders. <span><span class="ref-journal">Postgrad Med. </span>2000;<span class="ref-vol">107</span>:145–56.</span> [<a href="/pubmed/10728141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10728141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.shimmin.2007.434">Shimmin LC, Natarajan S, Ibarguen H, Montasser M, Kim DK, Hanis CL, Boerwinkle E, Wadhwa PD, Hixson JE. Corticotropin releasing hormone (CRH) gene variation: comprehensive resequencing for variant and molecular haplotype discovery in monosomic hybrid cell lines. <span><span class="ref-journal">DNA Seq. </span>2007;<span class="ref-vol">18</span>:434–44.</span> [<a href="/pubmed/17676473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17676473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.steinlein.2014.1">Steinlein OK. Genetic heterogeneity in familial nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Prog Brain Res. </span>2014;<span class="ref-vol">213</span>:1–15.</span> [<a href="/pubmed/25194481" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25194481</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.steinlein.2012.118">Steinlein OK, Hoda JC, Bertrand S, Bertrand D. Mutations in familial nocturnal frontal lobe epilepsy might be associated with distinct neurological phenotypes. <span><span class="ref-journal">Seizure. </span>2012;<span class="ref-vol">21</span>:118–23.</span> [<a href="/pubmed/22036597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22036597</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.steinlein.1997.943">Steinlein OK, Magnusson A, Stoodt J, Bertrand S, Weiland S, Berkovic SF, Nakken KO, Propping P, Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:943–7.</span> [<a href="/pubmed/9175743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9175743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.steinlein.2000.529">Steinlein OK, Stoodt J, Mulley J, Berkovic S, Scheffer IE, Brodtkorb E. Independent occurrence of the CHRNA4 Ser248Phe mutation in a Norwegian family with nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Epilepsia. </span>2000;<span class="ref-vol">41</span>:529–35.</span> [<a href="/pubmed/10802757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10802757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.steinlein.1996.289">Steinlein O, Weiland S, Stoodt J, Propping P. Exon-intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4). <span><span class="ref-journal">Genomics. </span>1996;<span class="ref-vol">32</span>:289–94.</span> [<a href="/pubmed/8833159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8833159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.tassinari.1997">Tassinari CA, Michelucci R. Familial frontal and temporal lobe epilepsy. In: Engel JJ, Pedley TA, eds. <em>Epilepsy: A Comprehensive Textbook.</em> Philadelphia, PA: Lippincott-Raven Publishers; 1997:2427-31.</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.tenchini.1999.637">Tenchini ML, Duga S, Bonati MT, Asselta R, Oldani A, Zucconi M, Malcovati M, Dalpra L, Ferini-Strambi L. SER252PHE and 776INS3 mutations in the CHRNA4 gene are rare in the Italian ADNFLE population. <span><span class="ref-journal">Sleep. </span>1999;<span class="ref-vol">22</span>:637–9.</span> [<a href="/pubmed/10450598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10450598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.trivisano.2015.e53">Trivisano M, Terracciano A, Milano T, Cappelletti S, Pietrafusa Nm Bertini ES, Vigevano F, Specchio N. Mutation of CHRNA2 in a family with benign familial infantile seizures: Potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:e53–7.</span> [<a href="/pubmed/25847220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25847220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.weiland.1996.433">Weiland S, Steinlein O. Dinucleotide polymorphism in the first intron of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4). <span><span class="ref-journal">Clin Genet. </span>1996;<span class="ref-vol">50</span>:433–4.</span> [<a href="/pubmed/9007339" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9007339</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="adnfle.REF.wood.2010.531">Wood AG, Saling MM, Fedi M, Berkovic SF, Scheffer IE, Benjamin C, Reutens DC. Neuropsychological function in patients with a single gene mutation associated with autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Epilepsy Behav. </span>2010;<span class="ref-vol">17</span>:531–5.</span> [<a href="/pubmed/20189461" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20189461</span></a>]</div></li></ul></div></div><div id="adnfle.Chapter_Notes"><h2 id="_adnfle_Chapter_Notes_">Chapter Notes</h2><div id="adnfle.Author_History"><h3>Author History</h3><p>Judith Adams, MBBS, FRACP; University of Melbourne (2002-2004)
<br />Samuel F Berkovic, MD, FRACP; Epilepsy Research Institute (2002-2010) <br />Shinichi Hirose, MD, PhD (2010-present)<br />Hirokazu Kurahashi, MD, PhD (2010-present)<br />Ingrid E Scheffer, MBBS, FRACP, PhD; Austin and Repatriation Medical Centre (2002-2010)</p></div><div id="adnfle.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>15 March 2018 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 February 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 September 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 April 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 June 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 January 2004 (cd) Revision: mutation detection rate</div></li><li class="half_rhythm"><div>16 May 2002 (me) Review posted live</div></li><li class="half_rhythm"><div>22 January 2002 (ja) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1169</span><span class="label">PMID: <a href="/pubmed/20301348" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301348</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lad-ad/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rob-ad/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1169&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1169/?report=reader">PubReader</a></li><li><a href="/books/NBK1169/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1169" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1169" style="display:none" title="Cite this Page"><div class="bk_tt">Kurahashi H, Hirose S. Autosomal Dominant Nocturnal Frontal Lobe Epilepsy. 2002 May 16 [Updated 2018 Mar 15]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1169/pdf/Bookshelf_NBK1169.pdf">PDF version of this page</a> (504K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#adnfle.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#adnfle.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#adnfle.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#adnfle.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#adnfle.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#adnfle.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#adnfle.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#adnfle.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#adnfle.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#adnfle.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#adnfle.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1135[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHRNA2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1137[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHRNA4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57582[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1141[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHRNB2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1169+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1458978" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1458978" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1458978" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1458978" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234941" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gertler T, Bearden D, Bhattacharjee A, Carvill G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27683934" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DEPDC5</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DEPDC5</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Baulac S, Weckhuysen S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15843070" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: "understanding the nicotinic acetylcholine receptor (nAChR)".</a><span class="source">[Eur J Paediatr Neurol. 2005]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: "understanding the nicotinic acetylcholine receptor (nAChR)".<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">di Corcia G, Blasetti A, De Simone M, Verrotti A, Chiarelli F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Paediatr Neurol. 2005; 9(2):59-66. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301709" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Epilepsy with Auditory Features</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Epilepsy with Auditory Features<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Michelucci R, Nobile C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301348" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301348" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041536dd21425a2500e951">Autosomal Dominant Nocturnal Frontal Lobe Epilepsy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Autosomal Dominant Nocturnal Frontal Lobe Epilepsy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:04:38-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D2BCFE040E3F10000000003080119&amp;ncbi_session=CE8D2BCFE0415361_0776SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1169%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1169&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1169/&amp;ncbi_pagename=Autosomal Dominant Nocturnal Frontal Lobe Epilepsy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D2BCFE0415361_0776SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>